国际麻醉学与复苏杂志   2022, Issue (11): 0-0
    
右美托咪定滴鼻联合低浓度七氟醚吸入用于小儿增强CT扫描的镇静效果
吴裕超, 王炫1()
1.厦门市儿童医院
Efficacy of intranasal dexmedetomidine combined with low‑concentration sevoflurane inhalation for enhanced CT sedation in children
 全文:
摘要:

目的 观察右美托美咪定滴鼻联合低浓度七氟醚面罩吸入用于小儿增强CT扫描的镇静效果。 方法 100例1~5岁行增强CT扫描检查的小儿,性别不限,按随机数字表法分为水合氯醛组(C组,34例)、右美托咪定组(D组,33例)和右美托咪定联合七氟醚组(DS组,33例)。C组患儿予经直肠灌注0.5 ml/kg 10%水合氯醛;D组患儿予3 μg/kg右美托咪定滴鼻;DS组患儿予3 μg/kg右美托咪定滴鼻,面罩吸入2%~3%七氟醚;给药后所有患儿Ramsay镇静评分达到4分或以上,行增强CT扫描。记录3组患儿一次镇静成功率(未完成增强CT扫描定义为镇静失败),记录达到预期镇静目标时间、复苏时间、镇静效果满意度,以及整个监护期间的不良事件,包括缺氧、呼吸抑制、心率下降、血压下降等。 结果 3组患儿一次镇静成功率分别为DS组97.0%、C组73.6%、D组87.9%。DS组患儿达到预期镇静目标时间为(4.0±0.8) min,短于C组[(21.9±7.4) min,P<0.001]和D组[(32.3±8.3) min,P<0.001],差异有统计学意义;C组达到预期镇静目标时间短于D组[(21.9±7.4) min 比 (32.3±8.3) min,P<0.001],差异有统计学意义。C组患儿复苏时间为(77.1±19.1) min,长于D组[(57.0±21.7) min,P<0.001]和DS组[(60.0±23.9) min,P<0.001],差异有统计学意义;D组复苏时间和DS组比较[(57.0±21.7) min 比 (60.0±23.9) min,P=0.262]差异无统计学意义。DS组镇静效果满意度为(8.9±0.4)分,高于C组[(7.5±2.3)分,P<0.001],差异有统计学意义,与D组比较[(8.0±1.6)分,P=0.269],差异无统计学意义;C组镇静效果满意度低于D组[(7.5±2.3)分 比 (8.0±1.6)分,P<0.001],差异有统计学意义。3组患儿共有5例患儿心率下降;部分患儿血压下降,但降幅都没有同龄儿童正常值的20%;所有患儿无呼吸抑制、缺氧事件。 结论 右美托咪定滴鼻联合低浓度七氟醚吸入用于小儿增强CT扫描镇静与单用右美咪定或水合氯醛相比,能有效提高成功率。

关键词: 右美托咪定; 七氟醚; 小儿; 镇静; 增强CT
Abstract:

Objective To observe the effect of intranasal dexmedetomidine combined with mask inhalation of low‑concentration sevoflurane for enhanced CT sedation in children. Methods A total of 100 children aged 1−5 y who underwent enhanced CT were enrolled. According to the random number table method, they were divided into three groups: a chloral hydrate group (group C,n=34), a dexmedetomidine group (group D,n=33) and a dexmedetomidine combined with sevoflurane group (group DS,n=33). Children in group C were transrectally perfusioned with 10% chloral hydrate at 0.5 ml/kg, while those in group D were treated with 3 μg/kg dexmedetomidine nasal drip. The children in group DS were treated with 3 μg/kg dexmedetomidine nasal drip and mask inhalation of 2%−3% sevoflurane. Then, their Ramsay score reached 4 or more, and enhanced CT scanning was performed. The success rate of sedation in the three groups was recorded (uncompleted enhanced CT scan was defined as sedation failure). The time to achieve the expected sedation time, recovery time, and the examiner's satisfaction with sedation were recorded. The adverse events during the whole monitoring period were recorded, including hypoxia, respiratory inhibition, and decreased heart rate and hypotension. Results The success rate of sedation in group DS was 97.0%, which was higher than that in group C (73.6%) and group D (87.9%). The time to achieve the expected sedation in group DS was (4.0±0.8) min, which was significantly shorter than that in group C [(21.9 ±7.4) min, P<0.001] and group D [(32.3±8.3) min, P<0.001]. The time to achieve the expected sedation in group C was significantly shorter than that in group D [(21.9 ±7.4) min VS (32.3 ±8.3) min, P<0.001]. The recovery time in group C was (77.1±19.1) min, which were significantly longer than that in group D [(57.0±21.7) min, P<0.001] and group DS [(60.0±23.9) min, P<0.001]. There was no significant difference in the recovery time between group D and group DS [(57.0±21.7) min VS (60.0±23.9) min, P=0.262]. The examiner's satisfaction in DS group was (8.9±0.4) scores, which were significantly higher than those in group C [(7.5±2.3) scores, P<0.001],without significant difference with group DS [(8.0±1.6) scores,P=0.269]. The examiner's satisfaction in group C was significantly lower than that ub group D [(7.5±2.3) scores VS (8.0±1.6) scores,P<0.001]. A total of 5 children in the three groups showed over 20% baseline decreases in heart rate, without over 20% decreases in blood pressure. There were no cases of respiratory inhibition, hypoxia events and other adverse events. Conclusion Compared with dexmedetomidine alone or dexmedetomidine plus chloral hydrate, intranasal dexmedetomidine combined with low‑concentration sevoflurane inhalation is useful for enhanced CT sedation in children can effectively improve the success rate.

Key words: Dexmedetomidine; Sevoflurane; Children; Sedation; Enhanced CT